Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu
  • quotes

  • charts

  • technicals

  • company

Tetra Bio-Pharma Inc (TBPMF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4650 +13.91%
on 06/05/18
0.5887 -10.02%
on 05/22/18
-0.0583 (-9.91%)
since 05/21/18
3-Month
0.4650 +13.91%
on 06/05/18
0.7636 -30.63%
on 03/22/18
-0.2272 (-30.02%)
since 03/21/18
52-Week
0.4550 +16.42%
on 11/07/17
1.4100 -62.43%
on 01/22/18
-0.1203 (-18.51%)
since 06/21/17

Most Recent Stories

More News
Tetra Bio-Pharma Adds a New Leader for its Commercial Operations

Tetra Bio-Pharma Inc., a leader in cannabinoid-based drug discovery and development (TSX VENTURE:TBP) (OTCQB:TBPMF), is pleased to announce that Mr. Richard Giguere has been hired as Executive Vice-President,...

TBPMF : 0.5297 (+1.67%)
TBP.VN : 0.700 (unch)
Tetra Bio-Pharma Takes on Fentanyl in Head to Head Trial for the Treatment of Breakthrough Pain

Tetra Bio-Pharma Inc., a leader in cannabinoid-based drug discovery and development (TSX VENTURE:TBP) (OTCQB:TBPMF), is pleased to announce that Sante Cannabis, the independently credentialed research...

TBPMF : 0.5297 (+1.67%)
TBP.VN : 0.700 (unch)
Tetra Bio-Pharma Inc. Provides Corporate Update Ahead of Its Annual General Meeting

Tetra Bio-Pharma Inc. ("Tetra" or the "Corporation") (TSX VENTURE:TBP) (OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, is pleased to provide a Corporate Update on its...

TBPMF : 0.5297 (+1.67%)
TBP.VN : 0.700 (unch)
Tetra Bio-Pharma Inc. Announces Changes Relating to the Nomination of its Directors

Tetra Bio-Pharma Inc. ("Tetra" or the "Corporation") (TSXV: TBP) (OTCQB: TBPMF), a global leader in cannabinoid-based drug development and discovery, wishes to announce that Mr. André Rancourt has advised...

TBPMF : 0.5297 (+1.67%)
TBP.VN : 0.700 (unch)
Tetra Bio-Pharma Inc. Strengthens Senior Management Team

Tetra Bio-Pharma Inc., a leader in cannabinoid-based drug discovery and development (TSX-V:TBP) (OTCQB:TBPMF), has strengthened its management team with the promotion of V.P. Financing and Business Development...

TBPMF : 0.5297 (+1.67%)
TBP.VN : 0.700 (unch)
Tetra Bio-Pharma Inc. Announces Listing of Warrants

Tetra Bio-Pharma Inc. Announces Listing of Warrants

TBPMF : 0.5297 (+1.67%)
TBP.VN : 0.700 (unch)
Namaste Announces Medical Cannabis Supply Agreement with Tetra Natural Health, to Sell RX Princeps Through Cannmart

Namaste Announces Medical Cannabis Supply Agreement with Tetra Natural Health, to Sell RX Princeps Through Cannmart

TBPMF : 0.5297 (+1.67%)
NXTTF : 1.1380 (-0.52%)
TBP.VN : 0.700 (unch)
N.VN : 1.480 (-2.63%)
Tetra BioPharma Signs Second Commercialization Deal with Azevedos Industria Farmaceutica, S.A. for the Lead RX product PPP001

Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX-V:TBP) (OTCQB:TBPMF), and Azevedos Industria Farmaceutica, S.A. announced that they have signed a binding term sheet for the marketing and distribution...

TBPMF : 0.5297 (+1.67%)
TBP.VN : 0.700 (unch)
Tetra Bio-Pharma Clinical Study on Cannabis Oil Capsules for Patients Suffering from Chronic Pain should be completed by Fall 2018

OTTAWA, ONTARIO--(Marketwired - April 12, 2018) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP) (OTCQB:TBPMF), provides a status report on its encapsulated cannabis oils (PPP005) clinical...

TBPMF : 0.5297 (+1.67%)
Tetra Bio-Pharma Announces the appointment of Gregory Drohan to its board of directors

OTTAWA, ONTARIO--(Marketwired - April 10, 2018) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, announced...

TBPMF : 0.5297 (+1.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade TBPMF with:

Key Turning Points

2nd Resistance Point 0.5535
1st Resistance Point 0.5416
Last Price 0.5297
1st Support Level 0.5089
2nd Support Level 0.4881

See More

52-Week High 1.4100
Fibonacci 61.8% 1.0452
Fibonacci 50% 0.9325
Fibonacci 38.2% 0.8198
Last Price 0.5297
52-Week Low 0.4550

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar